Elsevier

The Lancet

Volume 312, Issue 8079, 1 July 1978, Pages 7-9
The Lancet

TREATMENT OF EARLY BREAST CANCER

https://doi.org/10.1016/S0140-6736(78)91320-XGet rights and content

Abstract

The early follow-up of patients treated by simple mastectomy alone or simple mastectomy combined with radical radiotherapy is presented. Both groups were well matched for age, menopausal status, duration of symptoms, size of tumour, and lymph-node involvement. There was no significant difference in survival of patients in the two groups at three years, but local recurrence was significantly more frequent (28%) in the mastectomy-alone patients. Early survival was not adversely affected by radiotherapy.

References (15)

  • J. Stjernsward

    Lancet

    (1974)
  • A.M. McDonald et al.

    Lancet

    (1976)
  • I.W.J. Wallace et al.

    Lancet

    (1972)
  • M.M. Roberts et al.

    Lancet

    (1973)
  • J.P. Lythgoe et al.

    Lancet

    (1978)
  • E.C. Easson
  • B. Fisher et al.

    Ann. Surg.

    (1970)
There are more references available in the full text version of this article.

Cited by (29)

  • Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis

    2022, Surgery (United States)
    Citation Excerpt :

    Importantly, in our study, no survival benefit was observed in patients ≤40 years who underwent bilateral mastectomy. More extensive axillary surgery did not improve survival outcomes in any age group, consistent with evidence from multiple clinical trials demonstrating that ALND does not impact survival.23–26 These results are particularly important for the youngest group of TNBC patients, in whom more extensive surgical procedures were most commonly performed, perhaps unnecessarily.

  • De-escalating axillary surgery in early-stage breast cancer

    2022, Breast
    Citation Excerpt :

    It has long been recognized that axillary surgery does not impact survival. This was first demonstrated in the landmark NSABP B-04 and Kings/Cambridge trials where patients with operable breast cancer and clinically negative axillae (cN0) were randomized to variations of axillary management [1,2]. Notably, in both trials, axillary treatment (surgery or radiation) did not impact overall survival yet did contribute substantially to local control.

  • Modified radical mastectomy and simple mastectomy

    2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
  • Modified Radical Mastectomy and Total (Simple) Mastectomy

    2009, The Breast: Comprehensive Management of Benign and Malignant Diseases
View all citing articles on Scopus
View full text